Device Advice - Issue 16
- Feedback sought on provisional agreements for sterilisation products and related consumables.
- RFP process coming soon to improve orthopaedic product prices (without restricting choice).
- RFP process also coming soon for vascular compression therapy devices.
In this issue:
We've come a long way together since 2012 when PHARMAC started collaborating with DHBs on hospital medical devices work. We've spent a lot of time consulting on this work and what categories we would begin national contracting in.
As of 1 April 2016 we have listed 15,500 items, across 23 contracts, in 5 of the 12 categories. The savings to DHBs are estimated to be at least $20 million over 5 years, based on current usage. National contracting is just the beginning of our work and is already providing savings to DHBs on items that they are already purchasing, with no change required.
We are well underway to having activity in all 12 categories by the end of the year. Over the next few months, we’ll be consulting with you on what areas PHARMAC should look at next. Our work in hospital medical devices has been built on good engagement and consultation with the sector and wider stakeholders. Sector input has, and will continue to be essential for us to succeed in delivering the full benefits of a national management approach. We will continue to keep you updated on our thinking and when we will be seeking your feedback on this.
PHARMAC has recently been reviewing the approach to our work in the orthopaedic implants category. We now plan to issue a Request for Proposals (RFP) in April which will cover a greater range of orthopaedic products.
Orthopaedics is one of the 12 categories that were identified in consultation with the sector for PHARMAC to begin initial medical devices work. We have previously explored some contracting in this category and have a national contract with Stryker for a range of orthopaedic trauma, spine and cranio-maxillofacial implants.
The objective of the RFP is to clarify the roles and responsibilities of various agencies undertaking work in orthopaedic sub-categories, provide a panel of contracts for DHBs to purchase from, and gain a more thorough understanding of the current market.
The national contracting stage will not restrict DHBs product selection, and DHBs can continue using the products that they currently purchase. However, if DHBs are using products included in PHARMAC national contracts, they would be required to buy these products at the PHARMAC negotiated terms and conditions.
The RFP will be published on PHARMACs website as well as the NZ Government Electronic Tenders Services (GETS).
We’re currently seeking feedback on provisional agreements with three suppliers of sterilisation packaging products and associated consumables. The consultation is seeking feedback on agreements with three suppliers for the following product ranges:
- 3M New Zealand– sterilisation assurance indicators
- Intermed Medical Ltd – sterilisation packaging products, indicator tape and seal controls
- Jackson Allison Medical & Surgical Ltd – sterilisation packaging products and sterilisation assurance indicators
PHARMAC are continuing negotiations with suppliers of sterilisation packaging products and associated consumables.
Please send your feedback through to us by Friday 29 April 2016.
The Request for Proposals (RFP) for the supply of medical thermometer products has now closed. We are pleased with the level of interest and proposals that we received as part of this process.
We are now evaluating the proposals that we received and will be negotiating national contract agreements over the coming months for Pharmaceutical Schedule listings.
We previously advised that we would be releasing RFPs for both mechanical compression devices (intermittent pneumatic compression devices and venous foot pumps) and anti-embolism stockings (graduated compression stockings).
We now intend on releasing one RFP in April for vascular compression therapy devices for the prevention of venous thromboembolisms (VTEs) in hospitalised patients. This RFP will encompass the devices and related products used in the prevention of VTEs. The RFP will be released in April on GETS as well as the PHARMAC website.
Last updated: 26 January 2017